Drug profile · INN
romidepsin
ISTODAX
- US status
- approved
- Patents linked
- 0
- News articles
- 0
Quick answer
romidepsin (ISTODAX) is an FDA-listed pharmaceutical active ingredient. Associated with Teva Pharma GmbH. Route of administration: intravenous. Current US regulatory status: approved.
Key facts
INN romidepsin
Brand ISTODAX
Route INTRAVENOUS
Formulation POWDER
ATC code L01XX39
Originator Teva Pharma GmbH
Frequently asked questions
What is romidepsin?
romidepsin (ISTODAX) is an FDA-listed pharmaceutical active ingredient. Associated with Teva Pharma GmbH. Route of administration: intravenous. Current US regulatory status: approved.
What is the brand name for romidepsin?
ISTODAX is a marketed brand name for romidepsin. Check FDA Drugs@FDA for the current US label holder and prescribing information.
What is the US approval status of romidepsin?
romidepsin has approved status in the United States according to our Drugs@FDA-derived records. Verify on the official FDA label before clinical or commercial decisions.